Hu, Guilan
Zhu, Wenjia
Liu, Yu
Wang, Yuan
Zhang, Zheng
Zhu, Shikun
Duan, Wenwen
Zhou, Peipei
Fu, Chao
Li, Fang
Funding for this research was provided by:
National Key Research and Development Program of China (2016YFC0901500, 2020YFC2002702)
CAMS initiative for Rare Diseases Research Program (2016ZX310174-4)
Innovative Research Group Project of the National Natural Science Foundation of China (82071967)
Article History
Received: 29 September 2021
Accepted: 17 February 2022
First Online: 26 March 2022
Declarations
:
: All animal studies were performed in accordance with the guidelines of Animal Welfare Office of Peking Union Medical College, all procedures were reviewed and approved by the Institutional Animal Care and Use Committee, and all the animals were maintained under isoflurane anesthesia during the model-building, injection, accumulation, and scanning periods to avoid animal suffering at each stage of the experiment.
: Wenwen Duan and Peipei Zhou: Employees of Zhejiang Doer Biologics Corporation. All authors declare that no conflicts of interest relevant to this article exist and that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.